Stay updated on Relatlimab + Nivolumab Bioavailability Clinical Trial
Sign up to get notified when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.

Latest updates to the Relatlimab + Nivolumab Bioavailability Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.4.2. The prior funding-lapse notice (v3.4.1) has been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a general site notice about funding and operation status, and updated the site revision tag from v3.4.0 to v3.4.1. These changes affect the website interface rather than the study details.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle and updated the revision label to v3.4.0, along with minor capitalization changes in labels like 'Last Update' and 'No FEAR Act'. These are UI and copy tweaks that do not affect study data or eligibility.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor site maintenance update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA dedicated Locations section now lists New Jersey, replacing the former New Jersey Locations, which improves visibility of where the trial is conducted. The HHS Vulnerability Disclosure footer link was removed.SummaryDifference0.2%

- Check85 days agoChange DetectedThe site revision label was updated to v3.3.2, replacing the previous v3.3.1 entry.SummaryDifference0.1%

Stay in the know with updates to Relatlimab + Nivolumab Bioavailability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab + Nivolumab Bioavailability Clinical Trial page.